A Boron Delivery Antibody (BDA) with Boronated Specific Residues: New Perspectives in Boron Neutron Capture Therapy from an In Silico Investigation
Boron Neutron Capture Therapy (BNCT) is a tumor cell-selective radiotherapy based on a nuclear reaction that occurs when the isotope boron-10 (<sup>10</sup>B) is radiated by low-energy thermal neutrons or epithermal neutrons, triggering a nuclear fission response and enabling a selective...
| Main Authors: | Alessandro Rondina, Paola Fossa, Alessandro Orro, Luciano Milanesi, Antonella De Palma, Davide Perico, Pier Luigi Mauri, Pasqualina D’Ursi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/10/11/3225 |
Similar Items
-
A Red-Emitting Fluorescence Sensor for Detecting Boronic Acid-Containing Agents in Cells
by: Naoya Kondo, et al.
Published: (2022-10-01) -
A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy
by: Makoto Shirakawa, et al.
Published: (2021-12-01) -
Boron Neutron Capture Therapy: A Review of Clinical Applications
by: Timothy D. Malouff, et al.
Published: (2021-02-01) -
Evaluation of 3-Borono-<span style="font-variant: small-caps">l</span>-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent
by: Naoya Kondo, et al.
Published: (2022-05-01) -
The basis and advances in clinical application of boron neutron capture therapy
by: Huifang He, et al.
Published: (2021-11-01)